Literature DB >> 2542956

Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle.

K Goto1, Y Kasuya, N Matsuki, Y Takuwa, H Kurihara, T Ishikawa, S Kimura, M Yanagisawa, T Masaki.   

Abstract

Endothelin is a potent endothelium-derived vasoconstrictor peptide recently characterized from porcine and human vascular endothelial cells. Here we provide evidence that endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in porcine coronary artery smooth muscle. The vasoconstrictor action of endothelin is efficiently antagonized by low doses of the dihydropyridine Ca2+-channel blocker nicardipine. Endothelin augments the Ca2+-induced contraction in a high-K+ depolarizing solution, markedly enhances high-threshold Ca2+-channel current on the whole-cell patch clamp recording, and causes a sustained increase in the intracellular Ca2+ that is largely dependent on extracellular Ca2+. These findings suggest that endothelin exerts its vasoconstrictor effect by either directly or indirectly activating the voltage-dependent Ca2+ channel.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542956      PMCID: PMC287252          DOI: 10.1073/pnas.86.10.3915

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Three types of neuronal calcium channel with different calcium agonist sensitivity.

Authors:  M C Nowycky; A P Fox; R W Tsien
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

Review 2.  Calcium channel ligands.

Authors:  D J Triggle; R A Janis
Journal:  Annu Rev Pharmacol Toxicol       Date:  1987       Impact factor: 13.820

Review 3.  Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers.

Authors:  A A Abdel-Latif
Journal:  Pharmacol Rev       Date:  1986-09       Impact factor: 25.468

Review 4.  Calcium channel modulation by neurotransmitters, enzymes and drugs.

Authors:  H Reuter
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

5.  Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels.

Authors:  M Schramm; G Thomas; R Towart; G Franckowiak
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

6.  Effects of procaine on pharmaco-mechanical coupling mechanisms activated by acetylcholine in smooth muscle cells of porcine coronary artery.

Authors:  H Ueno; K Sumimoto; T Hashimoto; M Hirata; H Kuriyama
Journal:  Circ Res       Date:  1987-03       Impact factor: 17.367

7.  The inositol tris/tetrakisphosphate pathway--demonstration of Ins(1,4,5)P3 3-kinase activity in animal tissues.

Authors:  R F Irvine; A J Letcher; J P Heslop; M J Berridge
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

Review 8.  Inositol trisphosphate, a novel second messenger in cellular signal transduction.

Authors:  M J Berridge; R F Irvine
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

Review 9.  Calcium antagonism and calcium entry blockade.

Authors:  T Godfraind; R Miller; M Wibo
Journal:  Pharmacol Rev       Date:  1986-12       Impact factor: 25.468

10.  Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery.

Authors:  Y Kanmura; T Itoh; H Kuriyama
Journal:  J Pharmacol Exp Ther       Date:  1984-12       Impact factor: 4.030

View more
  65 in total

1.  ET(A) receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathway.

Authors:  A M Evans; H J Cobban; G F Nixon
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Effects of potassium channel opener KRN4884 on human conduit arteries used as coronary bypass grafts.

Authors:  Z Ren; S Floten; A Furnary; M Liu; H Gately; J Swanson; A Ahmad; A P Yim; G W He
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

3.  Endothelin activates voltage-dependent Ca2+ current by a G protein-dependent mechanism in rabbit cardiac myocytes.

Authors:  M R Lauer; M D Gunn; W T Clusin
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

4.  Sensitivity of G-protein involved in endothelin-1-induced Ca2+ influx to pertussis toxin in porcine endothelial cells in situ.

Authors:  H Aoki; S Kobayashi; J Nishimura; H Kanaide
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Identification of the Ca2+ current activated by vasoconstrictors in vascular smooth muscle cells.

Authors:  C Van Renterghem; M Lazdunski
Journal:  Pflugers Arch       Date:  1994-11       Impact factor: 3.657

6.  Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.

Authors:  Hong-Qiang Feng; Nate D Weymouth; Don C Rockey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

7.  Voltage-insensitive Ca2+ channels and Ca2+/calmodulin-dependent protein kinases propagate signals from endothelin-1 receptors to the c-fos promoter.

Authors:  Y Wang; M S Simonson
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  Extracellular Mg(2+) blocks endothelin-1-induced contraction through the inhibition of non-selective cation channels in coronary smooth muscle.

Authors:  Eun A Ko; Won Sun Park; Yung E Earm
Journal:  Pflugers Arch       Date:  2004-07-16       Impact factor: 3.657

9.  Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid.

Authors:  P Gaetani; R Rodriguez y Baena; G Grignani; G Spanu; L Pacchiarini; P Paoletti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

Review 10.  Endothelins. A potential target for pharmacological intervention in diseases of the elderly.

Authors:  H Lévesque; N Moore; N Cailleux; V Richard; C Thuillez; H Courtois
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.